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During persistent infection, virus-specific T cells 
are either physically deleted or persist in an 
“exhausted” state, which is characterized by the 
decreased ability to lyse virally infected cells, 
proliferate, and produce the antiviral and im-
mune  stimulatory  cytokines  IL-2, TNF,  and 
IFN- (Gallimore et al., 1998; Zajac et al., 
1998; Wherry et al., 2003; Brooks et al., 2005). 
It is the culmination of these deficiencies that 
ultimately prevents viral clearance, leading to 
persistent infection. T cell exhaustion is ob-
served during many persistent viral infections, 
including HIV and hepatitis B and hepatitis C 
virus infection in humans and lymphocytic 
choriomeningitis  virus  (LCMV)  infection  in 
mice, indicating that prolonged viral replication 
institutes a similar T cell differentiation program 
(Klenerman and Hill, 2005). Interestingly, per-
sistent LCMV infection is eventually controlled 
from the periphery 60–80 d after infection 
via CD8 T cell– and B cell–dependent mecha-
nisms, both of which are regulated by CD4   
T cells (Battegay et al., 1994; Matloubian et al., 
1994; Zajac et al., 1998; Ciurea et al., 2001; 
Bergthaler et al., 2009). Consequently, effective 
CD4 T cell responses are required for the ulti-
mate  resolution  of  persistent  LCMV  infection 
(Battegay et al., 1994; Matloubian et al., 1994). 
However, it is unclear how exhausted CD4   
T  cells  are  able  to  sustain  diverse  immune   
cell types.
Depending on the level of TCR stimula-
tion and the composition of co-stimulatory and 
inflammatory signals, CD4 T cells differentiate 
into a variety of helper subsets that in turn or-
chestrate diverse immune responses. We have 
previously demonstrated that priming and ini-
tial CD4 T cell activation is similar after acute 
and persistent LCMV infection, indicating that 
exhaustion is not a programmed event, but 
rather a continual response to the antigenic en-
vironment (Brooks et al., 2006a), and raising 
the question as to how differentiation is altered 
during persistent infection. CD4 T cells con-
tinue to help CD8 T cells during persistent 
viral infection, allowing continued control over 
virus replication (Elsaesser et al., 2009; Fröhlich 
et al., 2009; Yi et al., 2009). Although the role 
of CD8 T cells and their differentiation path-
ways have been extensively analyzed in acute 
and persistent viral infection (Kaech et al., 2002; 
CORRESPONDENCE  
David G. Brooks: 
dbrooks@microbio.ucla.edu
Abbreviations used: Arm, Arm-
strong; Bcl6, B cell lymphoma  
6 protein; Cl 13, clone 13; 
CXCR5, chemokine receptor 5; 
GATA3, GATA3-binding 
protein; GC, germinal center; 
ICOS, inducible T cell co-
stimulator; LCMV, lymphocytic 
choriomeningitis virus; mRNA, 
messenger RNA; SA, streptavi-
din; SMARTA, LCMV-specific 
CD4 TCR transgenic; Tfh,  
T follicular helper.
Viral persistence redirects CD4 T cell 
differentiation toward T follicular helper cells
Laura M. Fahey,1,2 Elizabeth B. Wilson,1,2 Heidi Elsaesser,1,2  
Chris D. Fistonich,1,2 Dorian B. McGavern,3 and David G. Brooks1,2
1Department of Microbiology, Immunology, and Molecular Genetics and 2UCLA AIDS Institute, David Geffen School  
of Medicine, University of California, Los Angeles, Los Angeles, CA 90095
3National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892
CD4 T cell responses are crucial to prevent and control viral infection; however, virus-
specific CD4 T cell activity is considered to be rapidly lost during many persistent viral 
infections. This is largely caused by the fact that during viral persistence CD4 T cells do not 
produce the classical Th1 cytokines associated with control of acute viral infections. Con-
sidering that CD4 T cell help is critical for both CD8 T cell and B cell functions, it is unclear 
how CD4 T cells can lose responsiveness but continue to sustain long-term control of 
persistent viral replication. We now demonstrate that CD4 T cell function is not extin-
guished as a result of viral persistence. Instead, viral persistence and prolonged T cell 
receptor stimulation progressively redirects CD4 T cell development away from the Th1 
response induced during an acute infection toward T follicular helper cells. Importantly, this 
sustained CD4 T cell functionality is critical to maintain immunity and ultimately aid in the 
control of persistent viral infection.
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Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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sustain antiviral antibody production and to ultimately con-
trol persistent virus replication. Thus, we demonstrate that 
CD4 T cells are not without function during viral persis-
tence,  but  instead  that  their  developmental  program  is   
redirected from promoting memory T and B cell differen-
tiation after acute viral infection and toward a T helper subset 
that sustains multiple immune parameters to fight persistent 
viral infection.
RESULTS
Persistent viral infection drives progressive CD4 T follicular 
helper (Tfh) cell differentiation
Different environmental cues institute distinct CD4 T helper 
cell developmental programs. To delineate how viral persis-
tence affects CD4 T helper cell differentiation, C57BL6 
mice were infected with either LCMV-Armstrong (Arm) or 
LCMV-Clone 13 (Cl 13). LCMV-Arm generates an acute in-
fection that is cleared primarily by CD8 T cells within 8–10 d 
and generates memory T cells. LCMV-Cl 13 induces a per-
sistent infection characterized by the attenuation of CD4 
and CD8 T cells, but is eventually resolved from most pe-
ripheral tissues via CD4 T cell, CD8 T cell, and B cell depen-
dent mechanisms. Notably, LCMV-Arm and Cl 13 contain 
identical T  cell  epitopes,  allowing  for  a   
direct comparison of virus-specific T cell 
responses. To specifically identify and ana-
lyze  virus-specific  CD4 T  cells,  LCMV-
specific CD4 TCR transgenic (SMARTA) 
cells, which recognize the LCMV-derived 
peptide  GP61–80  in  the  context  of  I-Ab 
(Oxenius  et  al.,  1998),  were  transferred 
into  mice  before  infection.  Importantly, 
the LCMV-specific SMARTA cells behave 
similarly to their endogenous (host-derived) 
CD4 T cell counterparts (Brooks et al., 2005, 
2006a; Elsaesser et al., 2009).
Wherry  et  al.,  2007),  CD4 T  cell  differentiation  and  the 
mechanisms that govern it are largely uncharacterized. Re-
cently, we and others identified IL-21 as a critical component 
of CD4 T cell help during viral persistence (Elsaesser et al., 
2009; Fröhlich et al., 2009; Yi et al., 2009). CD8 T cells re-
quire IL-21 to maintain residual levels of immunological func-
tion, avoid deletion, and resolve persistent infection. IL-21 is 
also important for stimulating germinal center (GC) B cells 
and antibody production (Ozaki et al., 2002; Linterman et al., 
2010; Zotos et al., 2010), suggesting that CD4 T cells differ-
entiate into a subset capable of providing help to both B cells 
and CD8 T cells during persistent viral infection.
Given that ongoing antiviral immune responses contin-
ually exert control over virus replication throughout persis-
tent infection and that CD4 T cells play an integral role in 
this process, we sought to define how viral persistence im-
pacts CD4 T cell differentiation such that it is capable of 
maintaining antiviral immunity in the face of prolonged 
periods of viral replication. Herein, we establish that the 
prolonged antigenic stimulation during viral persistence drives 
a specific CD4 T cell developmental program leading to the 
progressive differentiation of T follicular helper cells. These 
CD4 T cells continue to function during viral persistence to 
Figure 1.  Tfh differentiation during viral persis-
tence. (A) Virus-specific (SMARTA) CD4 T cells were 
isolated from the spleen on day 9, 30, and 60 after 
LCMV-Arm or Cl 13 infection and were analyzed for 
the surface expression of CXCR5. The line graph indi-
cates the percentage ± SD of CXCR5+ SMARTA cells 
during LCMV-Arm (black, diamond) and Cl 13 (red, 
octagons) infection on day 9, 30, and 60. (B) SMARTA 
cells were isolated from the spleen on day 8 and 36 
after LCMV-Arm or Cl 13 infection and were analyzed 
for the surface expression of ICOS and OX40. The bar 
graph depicts the percentage ± SD of ICOS+, OX40+ 
SMARTA cells during LCMV-Arm (black) and Cl 13 
(red) infection on the indicated days. (C) The line 
graph indicates the number of Tfh SMARTA cells 
(CXCR5+; gray circles) and non-Tfh SMARTA cells 
(CXCR5; black squares) during LCMV-Arm (left) and 
Cl 13 (right) infection. Data are representative of 
three to five mice per group and of four individual 
experiments (*, P < 0.05).JEM VOL. 208, May 9, 2011 
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30 d after LCMV-Cl 13 infection, we observed CD4 T cells 
localized to B cell areas in follicular-like structures with the 
virus-specific CD4 T cells in close proximity and intermin-
gled with the B cells (Fig. 2). Thus, in accordance with the 
expression of Tfh-associated molecules, virus-specific CD4   
T cells are present in juxtaposition with B cells, consistent 
with their need to provide ongoing help to B cells.
To determine if Tfh cell differentiation occurs in other 
organs during persistent viral infection, we assessed the effec-
tor molecule profile of virus-specific CD4 T cells within the 
liver and mesenteric LN. Early after infection (day 8), virus-
specific CD4 T cells in the liver (a nonlymphoid organ not 
associated with B cell GCs), and mesenteric LN expressed 
similar levels of CXCR5, ICOS, and OX40 (Fig. S2). As viral 
replication persisted, expression of CXCR5 on virus-specific 
Early after infection (day 8 and 9), both LCMV-Arm and 
Cl 13 induced the up-regulation of the Tfh cell–associated 
effector molecules CXC chemokine receptor 5 (CXCR5), 
inducible T cell co-stimulator (ICOS), and OX40 on virus-
specific CD4 T cells (Fig. 1, A and B). Tfh cells are recognized 
as a distinct CD4 T cell subset (CXCR5+, ICOS+, OX40+, 
and SLAMlow) and play a critical role in providing help to   
B cells (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 
2009). High expression of CXCR5 promotes the localization 
of CD4 T cells to B cell areas in lymphoid follicles, whereas 
ICOS and OX40 are effector molecules that augment Tfh cell 
differentiation, function, and survival (Linterman and  Vinuesa, 
2010). The expression of Tfh effector molecules decreased   
after resolution of LCMV-Arm infection (Fig. 1, A and B). 
Interestingly, as persistent infection progressed, the expression 
of CXCR5, ICOS, and OX40 increased, whereas the expres-
sion of SLAM decreased, which is indicative of enhanced Tfh 
development (Fig. 1, A and B, and Fig. S1 A). Notably, the vast 
majority of virus-specific CXCR5 expressing CD4 T cells 
coexpressed ICOS and OX40 (Fig. S1 B). Additionally, PD-1 
has been used to define Tfh cells (Haynes et al., 2007). How-
ever, it is not a useful indicator after LCMV infection because 
>98% of virus-specific CD4 T cells express PD-1 after both 
an acute and a persistent LCMV infection (Brooks et al., 
2006b) and >99% of virus-specific CD4 T cells continue to 
express PD-1 throughout persistent LCMV infection (un-
published data). Thus, after LCMV infection, essentially all 
virus-specific CD4 T cells express PD-1, precluding its use as 
a marker of Tfh. Comparable Tfh development was also ob-
served in the endogenous virus-specific CD4 T cell popula-
tion after LCMV infection (unpublished data), suggesting that 
prolonged viral replication leads to Tfh programming.
Similar to the percentage of cells expressing Tfh-associated 
molecules, the number of virus-specific Tfh cells (CD4+ 
CXCR5+) was higher in LCMV-Arm than Cl 13 on day 9 
after infection (Fig. 1 C). With the resolution of acute LCMV-
Arm infection, the number of virus-specific Tfh cells and 
non-Tfh cells (CD4+, CXCR5) decreased with the same 
kinetic. In contrast, as the persistent viral infection progressed 
the number of virus-specific Tfh cells slightly increased and 
was sustained, whereas the number of virus-specific non-Tfh 
cells steadily decreased compared with day 9 after infection 
(Fig. 1 C). The decline in virus-specific non-Tfh cells during 
persistent infection was likely not the result of non-Tfh cell 
egress from lymphoid organs to nonlymphoid organs because 
a consistent number of virus-specific Tfh and non-Tfh cells 
was observed in the liver over the duration of the infection 
(Fig. S1 C). Collectively, these data are consistent with our 
previous finding that IL-21 protein expression is initially 
lower in LCMV-Cl 13 compared with Arm infection, but in-
creases as persistent infection progresses (Elsaesser et al., 2009; 
Yi et al., 2009) and suggests that ongoing viral replication 
drives a distinct Th developmental program.
In addition to assessing the expression of Tfh effector 
molecules, we examined the location of virus-specific CD4   
T cells within the spleen during persistent viral infection.   
Figure 2.  Virus-specific CD4 T cells traffic to B cell areas during 
persistent viral infection. Day 30 LCMV-Cl 13–infected spleen sections 
were stained with antibodies to CD4 (green), CD45.1 (SMARTA cells; red), 
and B220 (B cells; blue). The top row is a merged image illustrating the 
location of all the three cell types. The white arrows in the image indicate 
SMARTA cells within B cell areas. The bottom two rows depict the two 
follicular-like structures outlined with white dotted lines in the top image. 
The last row depicting a follicular-like structure is rotated 90 degrees 
relative to the top image. The first column represents total CD4 T cells, the 
second column represents virus-specific SMARTA cells, the third column 
represents total B cells, and the last column is a merged image. The scale 
bar within each image corresponds to 100 µm. The image is represen-
tative of 5–13 different CD4 T cells cell areas per spleen and 5 indi-
vidual spleens.990 Viral persistence drives T follicular helper cell differentiation | Fahey et al.
and GATA3-binding protein (GATA3) mRNA and one- to 
twofold less T-bet mRNA compared with virus-specific CD4 
T cells 30 d after LCMV-Arm infection (Fig. 4 B). Consistent 
with the progressive differentiation toward CXCR5+, ICOS+, 
OX40+, SLAMlow–expressing Tfh cells during persistent in-
fection,  expression  of  the Tfh-associated  master  regulator, 
Bcl6, increased two to threefold between day 9 and 30 after 
LCMV-Cl 13 infection (Fig. 4 C). Interestingly, the molecular 
development of effector virus–specific CD4 T cells during 
persistent infection (day 30) is distinct from the effector re-
sponse observed during acute LCMV-Arm infection (day 9; 
Fig. 4 D), indicating that persistent infection does not delay 
the effector response observed during acute infection but in-
stead institutes a distinct developmental program. Further, 
virus-specific CD4 T cells expressed significantly higher levels 
of Bcl6 protein during persistent versus acute infection (Fig. 4 E). 
Increased levels of GATA3 mRNA were also observed dur-
ing persistent infection (Fig. 4, A–D), consistent with a recent 
finding that Tfh cells can express both Bcl6 and GATA3 
(Zaretsky et al., 2009). RORt mRNA or mRNA of the 
Th17-defining cytokines, IL-17a and IL-22, was not detected 
in virus-specific CD4 T cells during acute or persistent infec-
tion (unpublished data). Additionally, minimal FoxP3 protein 
expression was detectable in virus-specific CD4 T cells after 
either LCMV-Arm or Cl 13 (Fig. S3), collectively indicating 
that virus-specific CD4 T cells were not differentiating into 
Th17 or T reg cells.
Because virus-specific CD4 T cells expressed the Th2- 
associated transcriptional regulator, GATA3, during persistent 
infection, we measured the expression of Th2-associated cyto-
kines.  Virus-specific CD4 T cells from LCMV-Cl 13–infected 
mice did not express mRNA for IL-5, IL-9, or IL-13 (unpub-
lished data). Although the expression of IL-4 mRNA (a hall-
mark of Th2 and Tfh cells) was significantly increased (albeit 
at very low levels) during persistent infection, IL-4 protein 
expression was not detected after ex-vivo peptide stimulation 
and intracellular cytokine staining. Like the expression of ICOS, 
OX40, and Bcl6, mRNA for the transcription factor c-Maf, 
which is known to regulate IL-21 expression (Pot et al., 2009; 
Hiramatsu et al., 2010), was elevated during persistent infec-
tion and increased fourfold as infection persisted (unpublished 
data), further substantiating progressive Tfh differentiation.
The previous analyses were performed using the total 
population of virus-specific CD4 T cells (i.e., containing both 
Tfh and non-Tfh populations). To specifically delineate the 
contribution of virus-specific Tfh versus non-Tfh cells to-
ward the production of Th regulatory and effector molecules 
during persistent infection, we sorted each population and 
performed mRNA analysis. Virus-specific Tfh cells expressed 
significantly higher levels of Bcl6 in comparison to virus-
specific non-Tfh cells and naive virus-specific CD4 T cells, 
with the latter two populations expressing the same levels of 
Bcl6 (Fig. 4 F). In contrast, virus-specific non-Tfh cells ex-
pressed higher levels of T-bet, although both virus-specific 
populations expressed significantly more T-bet than naive   
virus-specific CD4 T cells (Fig. 4 F). Interestingly, GATA3 
CD4 T cells in the liver was maintained at a low level (al-
though it did not increase as observed in the spleen) and the 
expression of ICOS and OX40 was largely absent. In the 
mesenteric LN, the vast majority of virus-specific CD4   
T cells expressed CXCR5, ICOS, and OX40 (Fig. S2) at 
levels similar to those observed in the spleen (Fig. 1, A and B). 
Thus, progressive Tfh development is characteristic of CD4   
T cells in multiple lymphoid organs during viral persistence.
To differentiate whether viral persistence progressively 
drives Tfh development or preferentially sustains Tfh cells 
present early on in infection, we transferred CD4+, CXCR5 
(non-Tfh) SMARTA cells into LCMV-Cl 13–infected mice 
that had not initially received SMARTA cells. Importantly, 
the transfer was performed early (day 9) after infection and 
before the extensive Tfh differentiation observed later during 
infection. As persistent infection progressed, the transferred 
non-Tfh SMARTA cells increased CXCR5 expression (Fig. 3), 
indicating that Tfh development is a progressive response to 
persistent viral replication.
Tfh-associated master regulatory transcription factors  
are increased during viral persistence
To molecularly assess progressive virus-specific CD4 T cell 
differentiation during acute versus persistent viral infection, 
we quantified messenger RNA (mRNA) levels of the follow-
ing master transcription factors, which are known to regulate 
distinct Th fates: T-bet (Tbx21; Th1), GATA3-binding protein 
(GATA3; Th2), retinoid-related orphan receptor t (RORt; 
Th17), B cell lymphoma 6 protein (Bcl6; Tfh), and forkhead 
box P3 (FoxP3; T reg). Early after infection (day 9), virus-specific 
CD4 T cells in LCMV-Cl 13–infected mice expressed slightly 
lower levels of Bcl6, GATA3, and T-bet mRNA compared 
with LCMV-Arm–infected mice (Fig. 4 A), which is consistent 
with an attenuated phenotype (Brooks et al., 2005; Elsaesser 
et al., 2009). As persistent infection progressed (day 30), virus-
specific CD4 T cells expressed two- to threefold more Bcl6 
Figure 3.  Persistent viral replication drives non-Tfh cells to differ-
entiate into Tfh cells. SMARTA cells were transferred into WT mice and 
subsequently infected with LCMV-Cl 13. CD4+, CXCR5 (non-Tfh) cells 
were isolated on day 9 after infection and transferred into WT mice that 
had been infected with LCMV-Cl 13 (but that had not received SMARTA 
cells). The contour plots depict CXCR5 expression on sorted CD4 T cells 
pretransfer (left ) and SMARTA cells in the spleen 14 d after transfer 
(i.e., 23 d after infection) into LCMV-Cl 13–infected recipients. The bar 
graph depicts the percentage ± SD of CXCR5+, CD4 T cells before transfer 
(left) and after transfer (right). These data are representative of two indi-
vidual experiments containing four mice each (*, P < 0.05).JEM VOL. 208, May 9, 2011 
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CD4 T cells, but was highest in virus-specific non-Tfh cells 
compared with virus-specific Tfh cells. Thus, both subsets ex-
press Tbet, GATA3, Blimp-1, IL-21, IFN-, and slight levels 
of IL-4 during persistent infection; however, virus-specific 
Tfh cells produce more Bcl6 and IL-21 in vivo, whereas non-
Tfh cells express greater levels of IFN-, Blimp-1, and slightly 
more Tbet, providing molecular evidence that the Th subsets 
are developmentally and functionally distinct.
B cells are not required for Tfh development
We observed that the progressive differentiation of Tfh cells in 
lymphoid organs during persistent LCMV infection corre-
sponded with GC B cell development (Fig. S4). Based on this 
correlation and the reported need of B cell interaction for Tfh 
development (Haynes et al., 2007; Johnston et al., 2009), we 
assessed the contribution of B cells toward Tfh differentiation 
during viral persistence. Numerically, the amount of SMARTA 
cells was significantly less in persistently infected B cell–deficient 
(MT) mice compared with WT mice (Fig. 5 A), suggesting 
that virus-specific CD4 T cells require B cells for survival 
mRNA levels were comparable between virus-specific Tfh 
and non-Tfh populations, although the overall increase com-
pared with naive was not as great as observed for Tbet or for 
Bcl6 by Tfh cells (Fig. 4 F). Like that of Tbet, non-Tfh cells 
expressed greater levels of the Bcl6 antagonist, Blimp-1 
(Prdm1),  than Tfh  cells,  but  both  subsets  expressed  more 
Blimp-1 than naive virus-specific CD4 T cells. Although CD4 
T cell subsets expressed extremely low levels of IL-4 RNA, 
virus-specific Tfh cells expressed significantly more IL-4 than 
non-Tfh cells. However, both virus-specific populations ex-
pressed significantly higher levels of IL-4 than naive virus-
specific CD4  T cells (Fig. 4 F). IL-21 was expressed significantly 
higher in virus-specific Tfh cells compared with non-Tfh 
cells. Yet, unlike Bcl6 expression both virus-specific Tfh and 
non-Tfh expressed significantly more IL-21 than naive virus-
specific CD4 T cells (Fig. 4 F), potentially explaining how   
IL-21 mediated help can be provided to CD8 T cells despite 
the extensive progressive differentiation of CD4 T cells into 
Tfh cells. IFN- expression was higher in both virus-specific 
Tfh cells and non-Tfh cells compared with naive virus-specific 
Figure 4.  Persistent viral infection  
induces Tfh transcriptional master regu-
lators. SMARTA cells were FACS isolated 
from splenocytes on day 9 and 30 after 
LCMV-Arm or Cl 13 infection. mRNA expres-
sion was analyzed by quantitative RT-PCR. 
The results are presented as mean fold 
change in expression ± SD between SMARTA 
cells isolated from (A) LCMV-Cl 13 versus 
LCMV-Arm on day 9 after infection,  
(B) LCMV-Cl 13 versus LCMV-Arm on day 30 
after infection, (C) LCMV-Cl 13 on day 30 
versus day 9 after infection, or (D) LCMV-Cl 
13 on day 30 versus LCMV-Arm on day 9 after 
infection. Data are representative of four 
mice per group and two individual experiments   
(*, P < 0.05). (E) The histogram illustrates Bcl6 
expression in SMARTA cells on day 30 after 
LCMV-Arm (black) and Cl 13 infection (red). 
The gray line represents the isotype control. 
The bar graph on the right depicts the GMFI ± 
SD of Bcl6 in SMARTA cells. Data are rep-
resentative of four to five mice per group 
and three separate experiments (*, P < 0.05).  
(F) mRNA expression was analyzed by quan-
titative RT-PCR from naive virus-specific  
CD4 T cells (SMARTA), splenic Tfh (CD4+, 
Ly5.1+, CXCR5+), and non-Tfh (CD4+, Ly5.1+, 
CXCR5) SMARTA cells sorted 30 d after 
LCMV-Cl 13 infection. The results are pre-
sented as the mean relative mRNA expres-
sion ± SD. Data are representative of four to 
five groups (each group consisting of sorted 
cells from five to six mice) and two to three 
separate experiments. Note, IL-4 data are 
presented from one experiment containing 
five groups (each group consisting of sorted 
cells from five mice; *, P < 0.05).992 Viral persistence drives T follicular helper cell differentiation | Fahey et al.
On day 35 after infection (a time when viral replication is still 
high), T cells were harvested from these donor mice and 
transferred into either LCMV-immune or LCMV-Cl 13– 
infected WT mice that had been infected in parallel but had 
not received SMARTA cells. LCMV-immune mice are WT 
mice that cleared LCMV-Arm infection and contain LCMV-
specific memory T cells. LCMV-immune mice were chosen 
instead of naive mice to prevent infection from any virus po-
tentially carried over with the transfer. SMARTA cells trans-
ferred into LCMV-Cl 13–infected WT recipients expressed 
comparable levels of CXCR5, ICOS, and OX40, as observed 
before transfer, indicating the validity of the transfer system 
(Fig. 6 A). In contrast, the SMARTA cells transferred into 
LCMV-immune recipients displayed significantly decreased 
expression of CXCR5, ICOS, and OX40 (Fig. 6 A). Interest-
ingly, Bcl6 expression was similar in virus-specific CD4 T cells 
after adoptive transfer into LCMV-Arm or LCMV-Cl 13– 
infected mice (Fig. 6 A), suggesting that persistent viral infection 
institutes a prolonged molecular program of Tfh differentia-
tion, whereas constant immune-activating signals sustain Tfh 
effector molecules.
High-affinity  TCR  binding  and 
strong TCR signals are associated with 
Tfh development (Fazilleau et al., 2009). 
A major difference between acute and 
persistent infection is prolonged anti-
gen presentation and, consequently, 
TCR  signaling. To  specifically  assess 
the contribution of prolonged TCR 
signaling toward Tfh cell development 
during viral persistence, virus-specific 
CD4 T cells were isolated from LCMV-
Cl 13 persistently infected mice and 
transferred into LCMV-Cl 13–infected 
WT mice or LCMV-Cl 13–infected 
during persistent infection. Yet, virus-specific CD4 T cells 
from both WT and MT mice expressed comparable levels of 
CXCR5, ICOS, OX40, and Bcl6 during persistent infection 
(Fig. 5), indicating similar Tfh differentiation of the remaining 
virus-specific cells. On the other hand, B cells were required 
for Tfh development after acute LCMV-Arm infection (un-
published data) confirming previous findings (Johnston et al., 
2009). Thus, mechanisms present during persistent infection 
bypass the B cell requirement for Tfh differentiation.
TCR stimulation drives Tfh cell responses during persistent 
viral infection
Considering that B cells are not required for Tfh differentia-
tion during persistent infection, we next sought to define the 
mechanism that enhances the development of Tfh cells dur-
ing viral persistence. One of the main differences between 
acute and persistent viral infection is elevated and prolonged 
antigen stimulation and inflammatory signals (Hahm et al., 
2005; Shin et al., 2007). To determine how these factors contrib-
ute to Tfh development, we transferred SMARTA cells into 
WT mice and subsequently infected them with LCMV-Cl 13. 
Figure 5.  B cell–independent Tfh devel-
opment during persistent viral infection. 
(A) The flow plots illustrate CXCR5 expres-
sion on SMARTA cells from LCMV-Cl  
13–infected WT or MT mice. The left bar 
graphs indicate the percentage ± SD of 
CXCR5 + SMARTA cells and the right bar 
graph depicts the absolute number ± SD of 
SMARTA cells. (B) The flow plots show ICOS 
and OX40 expression on SMARTA cells from 
LCMV-Cl 13–infected WT or MT mice. Bar 
graphs indicate the percentage ± SD of 
ICOS+, OX40+ SMARTA cells. (C) The histo-
gram depicts Bcl6 expression within SMARTA 
cells isolated from WT (red) and MT (blue) 
mice 30 d after LCMV-Cl 13 infection. The 
gray line represents the isotype control. 
Numbers indicate the mean GMFI ± SD of 
Bcl6. Data are representative of three to four 
mice per group and three individual experi-
ments (*, P < 0.05).JEM VOL. 208, May 9, 2011 
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during viral persistence. Notably, the data are likely not a re-
sult of Tfh selection after transfer into LCMV-Cl 13 recipi-
ents because the number of SMARTA cells in the spleen on 
day 14 after transfer was similar in both LCMV-Arm and Cl 
13 recipients, and although there was less SMARTA cells in 
MHC class II–deficient recipients, this was likely caused by 
the lack of sustaining signals (Viret et al., 1999; Fig. 6 C).
CD4 T cells retain B cell helping function during  
viral persistence
Considering the important role of B cells in resolving per-
sistent LCMV infection (Recher et al., 2007; Bergthaler   
et al., 2009) and the specific development of CD4 T cells 
MHC class II–deficient mice. Importantly, LCMV-Cl 13– 
infected MHC class II–deficient recipient mice had signifi-
cantly  higher  levels  of  virus  replication  than  LCMV-Cl 
13–infected WT  recipient  mice  (MHC  class  II–deficient 
mice, 1.2 × 105 ± 3.2 × 104 PFU/ml serum; WT mice, 9.6 × 
103 ± 7.3 × 103 PFU/ml serum; P = 0.008) in the periphery 
14 d after cell transfer. Thus, MHC class II–deficient mice 
have other components of the immune activating environment, 
but cannot provide TCR stimulation to CD4 T cells. Despite the 
high levels of virus replication in the MHC class II–deficient 
mice, virus-specific CD4 T cells decreased the expression of 
the Tfh effector molecules (Fig. 6b), indicating that TCR 
signals  are  necessary  to  sustain Tfh  effector  differentiation 
Figure 6.  Sustained TCR stimulation drives Tfh differentiation during persistent viral infection. (A) SMARTA cells from LCMV-Cl 13–infected WT 
mice (left) were isolated on day 35 after infection and transferred into WT mice that had been infected with LCMV-Arm or Cl 13 35 d earlier (but that had 
not received SMARTA cells). The contour plots depict CXCR5, ICOS, and OX40 expression on SMARTA cells pretransfer (left) and 14 d after transfer into 
LCMV-Arm immune (top right) or LCMV-Cl 13–infected (bottom right) recipients. The bar graphs indicate the percentage ± SD of CXCR5+ or ICOS+, OX40+ 
SMARTA cells. The histogram illustrates Bcl6 expression in SMARTA cells 14 d after transfer into LCMV-Arm (black) and Cl 13 infection (red). The gray line 
represents the isotype control. Numbers indicate the mean GMFI ± SD of Bcl6 in each population. These data are representative of 4–6 mice per group 
and three individual experiments (*, P < 0.05). (B) SMARTA cells from LCMV-Cl 13–infected WT mice (left) were isolated on day 27 after infection and 
transferred into LCMV-Cl 13–infected WT C57BL6 or LCMV-Cl 13–infected MHC class II KO mice (all recipient mice were infected in parallel but had not 
received SMARTA cells). The contour plots illustrate CXCR5, ICOS and OX40 expression on SMARTA cells pretransfer (left panel) and fourteen days after 
transfer into LCMV-Cl 13–infected MHC Class II KO recipients (right). Bar graphs indicate the percentage ± SD of CXCR5+ or ICOS+, OX40+ SMARTA cells 
(*, P < 0.05). Data are representative of 3–5 mice per group and two individual experiments (C) The bar graph indicates the number ± SD of SMARTA cells 
in the spleen fourteen days after transfer. Data are representative of three to five mice per group and two individual experiments (*, P < 0.05).994 Viral persistence drives T follicular helper cell differentiation | Fahey et al.
(Fig. 7 A; day 11). However, progressive infection in the ab-
sence of sustained CD4 T cell help resulted in a threefold 
decrease in LCMV-specific antibody titers and a 3–4 fold 
decrease in the frequency and number of GC B cells com-
pared with isotype antibody-treated controls (Fig. 7 A). No-
tably, the total number of B cells was not affected by CD4 
depletion (Fig. 7 A), demonstrating that virus-specific CD4   
T cells remain functional and specifically sustain antiviral B 
cell activity as viral infection progresses. On the contrary, 
in response to CD4 T cell depletion 12 d after LCMV-Arm 
infection (a time point when the virus is cleared), LCMV-
specific  antibody  levels  continued  to  increase  and  CD4 
depletion led to only a minimal long-term effect on virus-
specific antibody production (Fig. S5 B). No reemergence 
of  viral  replication  was  observed.  Further,  although  the 
level of virus-specific antibody was decreased during per-
sistent  infection,  the  distribution  of  virus-specific  IgG   
antibody  isotypes  (IgG1,  IgG2a,  IgG2b,  and  IgG3)  was 
similar  (unpublished  data). These  data  demonstrate  that   
into Tfh cells, we sought to define whether CD4 T cells re-
tained specific B cell helping function during persistent 
infection. Ex vivo Tfh cells retained the ability to provide 
help to B cells during persistent infection (Fig. S5 A), sug-
gesting  that  in  vivo  helper  function  remains. To  further 
evaluate sustained in vivo helper function, we depleted CD4 
T cells both before and during infection and subsequently 
assessed antiviral B cell responses. Antibody depletion of 
CD4 T cells before infection almost entirely abrogated LCMV-
specific IgG antibody production (Fig. 7 A) because of the 
need  for  CD4 T  cell  help  to  generate  antiviral  B  cell 
responses. To define the ongoing need for CD4 T cell help, 
CD4 T cells were depleted 12 d after LCMV-Cl 13 infection 
(i.e., allowing for the initial programming and generation of 
B cell responses but before extensive Tfh differentiation) at 
a time when these cells are considered to be exhausted. 
Consistent with the initial provision of CD4 T cell help, 
LCMV-specific antibody production increased before depletion 
between isotype antibody and day 12 CD4-depleted mice 
Figure 7.  Tfh cell development is required to sustain LCMV-specific B cell responses during persistent viral infection. (A) Antiviral B cell re-
sponses during LCMV-Cl 13 infection in isotype antibody control treated mice versus day 0 or 12 CD4-depleted WT mice. The line graph depicts the serum 
concentration (nanogram/milliliter) ± SD of LCMV-specific IgG produced by mice injected with isotype control antibody (black circles), or mice depleted of 
CD4 T cells on day 0 (green triangles) or day 12 (gray diamonds) on the indicated day after infection. Flow plots illustrate the frequency of GC B cells 
(GL7+, Fas+ B cells) on day thirty-five after infection. The bar graphs indicate the number ± SD of total B cells (left bar graph) and GC B cells (right bar 
graph) during persistent LCMV-Cl 13 infection. (B) Antiviral B cell responses during LCMV-Cl 13 infection in WT (black, circles) versus CXCR5 KO mice 
(gray, inverted triangles). The same analyses were performed as described in A. (C) Serum viral titers after LCMV-Cl 13 infection of isotype antibody con-
trol (black, circles) versus day 12 CD4-depleted (gray, diamonds) mice (left) or WT (black, circles) versus CXCR5 KO (gray, inverted triangles) mice (right). 
Data are expressed as PFU per milliliter serum ± SD. The black, dashed line indicates the lower limit of detection (200 PFU/ml). Data are representative of 
three to six mice per group and three individual experiments (*, P < 0.05).JEM VOL. 208, May 9, 2011 
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increase of CXCR5 expression on CD4 T cells (i.e., Tfh-
mediated interactions) in an otherwise CXCR5-sufficient 
host, lethally irradiated WT mice were reconstituted with a 
mixture of bone marrow from CD4 KO (85%) and either 
WT (15%) or CXCR5 KO (15%) mice. In this manner, all 
hematopoietic cells are derived from the CD4 KO bone mar-
row, except for the CD4 T cells, which are consequently derived 
from the minority WT or CXCR5 KO bone marrow donor. 
As a result, mice in which CD4 T cells are CXCR5 sufficient 
(i.e., CD4 KO–WT chimeras) can directly be compared with 
mice in which only CD4 T cells lacked CXCR5 expression 
(i.e., CD4 KO–CXCR5 KO chimeras) to specifically define 
the role of Tfh interactions during viral persistence. In prelimi-
nary results, no difference in LCMV-specific antibody pro-
duction was initially observed between CD4 KO–WT and 
CD4 KO–CXCR5 KO bone marrow chimera mice after 
persistent LCMV-Cl 13 infection (Fig. S7), similar to mice 
depleted of CD4 T cells 12 d after infection and CXCR5 KO 
mice. However, as the infection progressed there was a greater 
than fourfold decrease in LCMV-specific antibody titers and 
a significant decrease in the frequency and number of GC   
B cells when CD4 T cells were incapable of expressing 
CXCR5 (Fig. S7). Thus, in combination with the results from 
the CD4 depletion and the CXCR5 KO mouse infection 
studies, the finding that antiviral B cell responses are invoked, 
but not sustained when only CD4 T cells lack CXCR5 ex-
pression, demonstrates that CD4 T cells retain important 
functions during persistent infection and that their progres-
sive Tfh interactions are critical to sustaining the antiviral   
B cell immunity through viral persistence.
DISCUSSION
The importance of CD4 T cell help during persistent infec-
tion has long been recognized; however, the mechanisms of 
CD4 T cell help have remained unclear. Collectively, our 
data demonstrate that CD4 T cells maintain important in vivo 
function during viral persistence. Instead of losing function, 
CD4 T helper cells differentiate toward Tfh responses that ac-
tively sustain immunity in the face of widespread immuno-
suppression and persistent viral replication. Increased Tfh 
responses during viral persistence are demonstrated by the 
up-regulation of phenotypic and effector molecules, location 
of virus-specific CD4 T cells within follicular structures and 
B cell areas and increased expression of master transcriptional 
regulators associated with Tfh cells. Further, the functionality 
and importance of these cells is illustrated ex vivo and in vivo 
by the finding that when physically depleted during infection 
or Tfh function is impaired, multiple parameters of antiviral 
B cell immunity are extinguished and the immune system is 
unable to gain control over virus replication.
The development of distinct CD4 T helper subsets is pro-
grammed by specific transcription factors; yet, multiple mas-
ter transcription regulators have been observed within a given 
cell (Zaretsky et al., 2009; Hegazy et al., 2010). Thus, in addi-
tion to their presence, the balance between the expression of 
these transcription factors is likely important in instituting a 
virus-specific CD4 T cells retain function during viral per-
sistence and exhibit a unique role in sustaining B cell re-
sponses not required after an acute infection.
To investigate the importance of the progressive Tfh dif-
ferentiation and their interaction with B cells without de-
pleting CD4 T cells, we infected CXCR5 KO mice with 
LCMV-Cl 13. CXCR5 is expressed on Tfh cells and mature 
B cells (Förster et al., 1996), and is required for proper fol-
licular organization (Förster et al., 1996; Voigt et al., 2000), 
efficient GC responses, and T cell homing into the B cell 
follicle (Förster et al., 1996; Haynes et al., 2007). Addition-
ally, CXCR5 is essential for the coordinated interaction of 
virus-specific CD4 T cells and B cells in the follicle (Junt   
et al., 2005). Therefore, in using CXCR5 KO mice, we can 
assess the requirement of follicular Tfh: B cell interactions 
during  persistent  viral  infection.  Interestingly,  similar  to 
CD4 T cell depletion on day 12 after persistent infection, no 
significant difference in LCMV-specific antibody produc-
tion was initially observed between WT and CXCR5 KO 
mice (day 9) after LCMV-Cl 13 infection (Fig. 7 B), sug-
gesting that the early interaction of CD4 T cells with B cells 
is less dependent on CXCR5-mediated homing to the fol-
licle, likely because of the splenic disorganization that oc-
curs early after infection (Odermatt et al., 1991). As persistent 
infection  progresses  and  splenic  architecture  is  restored, 
LCMV-specific antibody titers continued to increase in WT 
mice, whereas they failed to do so in CXCR5 KO mice 
(Fig. 7 B). This failure to progressively increase antibody 
production occurred despite similar numbers of virus-specific 
CD4 T cells (Fig. S6 A), suggesting that organized follicular 
CD4 T cell–B cell interactions are required during persis-
tent viral infection to sustain antiviral immunity. Again,   
although the total number of B cells was unaffected, the 
frequency and number of GC B cells was decreased in CXCR5 
KO mice compared with WT controls (Fig. 7 B), which is 
likely a consequence of reduced virus-specific CD4 T cell–B 
cell interactions (Junt et al., 2005). Conversely, LCMV anti-
body production continued to increase and was similar in 
WT and CXCR5 KO mice infected acutely with LCMV-
Arm (Fig. S5 C), indicating the unique need for ongoing 
CD4 T cell function and CD4 T cell–B cell interaction dur-
ing persistent infection.
Importantly, persistent virus replication was eventually 
resolved in isotype antibody-treated and in WT mice; whereas, 
virus titers remained high in the absence of ongoing CD4 
T cell help (i.e., day 12 CD4 T cell depletion) or lack of or-
ganized interactions with B cells (Fig. 7 C). Interestingly, like 
virus-specific CD4 T cells, the number and function of virus-
specific CD8 T cells was not decreased in CXCR5 KO mice 
(Fig. S6 B), again highlighting the importance of the ongoing 
interactions between virus-specific CD4 T cells with B cells 
to resolve persistent virus infection.
One caveat in using the CXCR5 KO mice is that B cells 
also do not express CXCR5, and as a result do not efficiently 
localize to or form follicles (Förster et al., 1996; Voigt et al., 
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hypergammaglobulinemia is observed during many persistent 
infections, including HIV and hepatitis C virus infections, 
and could potentially lead to autoimmune disorders or hinder 
antibody responses to secondary infections (Hunziker et al., 
2003; Recher et al., 2004). Thus, in addition to providing fac-
tors that sustain antiviral B cell and CD8 T cell responses (e.g., 
IL-21), the progressive differentiation of CD4 T cells may 
also have a detrimental effect of providing help to nonspecific 
B cells and, consequently, the hypergammaglobulinemia ob-
served during persistent viral replication.
Mechanistically, prolonged TCR signaling is essential for 
the progressive Tfh differentiation during viral persistence. 
High-affinity TCR interactions (translating into heightened 
TCR signaling) are important components of Tfh differen-
tiation (Fazilleau et al., 2009). Similar to high-affinity inter-
actions, our data suggest that excessive and prolonged TCR 
stimulation also specifically drives robust Tfh development. 
Yet, the CD4 T cell response generated during a persistent 
infection is not merely a delayed version of the response initi-
ated during an acute infection, but instead sustained TCR 
stimulation and potentially other factors supported by TCR–
MHC II interactions drives a molecularly and functionally 
distinct CD4 T cell developmental program. This unique dif-
ferentiation leads to the generation of CD4 Th cells capable 
of sustaining multiple immune cell populations (e.g., CD8   
T cells and B cells) that likely work together to eventually 
overcome the persistent infection.
The early decreased expression of multiple Th lineage 
factors and cytokines by CD4 T cells (e.g., IFN , TNF, IL-2, 
and  IL-21;  Fuller  and  Zajac,  2003;  Brooks  et  al.,  2005;   
Elsaesser et al., 2009; Fröhlich et al., 2009) suggests that CD4   
T cells may initially down-regulate their function during the 
height of viral replication, which is consistent with the ob-
served exhaustion. However, as viral infection progresses, the 
continued TCR stimulation progressively institutes a distinct 
and functional developmental program. Thus, the altered CD4 
T cell helper differentiation may be a means to initially limit 
more aggressive Th1 responses, and thus immunopathology 
(Barber et al., 2006), while progressively providing critical 
factors to sustain CD8 T cell and B cell effector responses to 
control virus replication (Elsaesser et al., 2009; Fröhlich et al., 
2009; Yi et al., 2009). Thus, our study establishes that CD4   
T cell function is not abolished but instead redirected by viral 
persistence. As a result of their sustained functionality, CD4   
T cells may be targets for redirective immunotherapies that 
specifically enhance or alter T helper function to ultimately 
eliminate persistent viral infections.
MATERIALS AND METHODS
Mice and virus. C57BL6 (WT) mice were purchased from The Jackson 
Laboratory or the rodent breeding colony at University of California, Los 
Angeles. MT, CD4 KO, MHC class II KO, and CXCR5 KO mice were 
purchased  from The  Jackson  Laboratory.  LCMV-GP61-80–specific  CD4+ 
TCR transgenic (SMARTA) mice have been described previously (Oxenius 
et al., 1998). All mice were housed under specific pathogen–free conditions. 
Mouse handling conformed to the experimental protocols approved by the 
University of California, Los Angeles Animal Research Committee (ARC). 
developmental program. During persistent viral infection, the 
expression of Bcl6 (Tfh master regulator) and c-Maf increased, 
whereas the expression of T-bet (Th1 master regulator) de-
creased in virus-specific CD4 T cells as virus replication pro-
gressed, consistent with the observed progressive development 
of Tfh cells. Accordingly, the greatest levels of Bcl6 and IL-21 
expression were observed in the Tfh subset of virus-specific 
CD4 T cells, whereas virus-specific non-Tfh cells expressed 
the greatest levels of Blimp-1, Tbet, and IFN- during persis-
tent infection. Even though the virus-specific Th subsets 
appear to be developmentally and functionally distinct, based 
on the mRNA levels of transcription factors and cytokines, 
both virus-specific Tfh and non-Tfh cells continually express 
significant levels of IL-21 and IFN- during persistent infec-
tion, again demonstrating that virus-specific CD4 T subsets 
retain ongoing function in the face of prolonged viral replica-
tion. Because both virus-specific Tfh and non-Tfh express IL-21 
in vivo, this may be an explanation of how IL-21-mediated help 
is provided to both B cells and CD8 T cells. Interestingly, the 
mRNA expression of the Th2 master regulator GATA3 also 
increased in the virus-specific CD4 T cell population during 
persistent viral replication, with comparable levels of GATA3 
observed in each virus-specific subset, Tfh, and non-Tfh. Yet, 
other Th2-associated effector molecules were either absent or 
expressed at extremely low levels (i.e., IL-4) in virus-specific 
CD4 T cells. Thus, our results are consistent with several re-
cent studies that indicate that Tfh cells can simultaneously ex-
press classically Th2-associated factors and with their role in 
helping B cells (Johnston et al., 2009; King and Mohrs, 2009; 
Reinhardt et al., 2009; Zaretsky et al., 2009). Such plasticity in 
CD4 T cells may be necessary to ensure that they can respond 
to changes in the antigenic environment and signal the effec-
tor arms of the immune response to respond accordingly.
In addition to dysfunctional CD8 T cell responses, im-
paired B cell and antibody responses can lead to viral persis-
tence (Thomsen et al., 1996; Bergthaler et al., 2009). B cells 
are also important in regulating the generation of Tfh cells 
(Nurieva et al., 2008; Johnston et al., 2009). However, during 
persistent infection in both WT and B cell–deficient mice, 
similar virus-specific CD4 Tfh development is observed, sug-
gesting that B cells may not be absolutely required for Tfh 
differentiation in the presence of prolonged antigenic stimu-
lation. Similarly, B cell–independent Tfh development was re-
cently demonstrated using a protein/adjuvant prime-boost 
strategy (Deenick et al., 2010). We now illustrate using an es-
tablished viral model in which antigen presentation is pro-
longed, that B cell–mediated instruction of Tfh differentiation 
can be bypassed by viral persistence. Although B cells are not 
necessary for Tfh development during viral persistence, we 
demonstrate that the progressive CD4 T cell response is con-
tinually required to maintain GC B cells and importantly 
sustain antiviral antibody production in the face of prolonged 
high levels of virus replication and immunosuppression. In 
addition to LCMV-specific antibodies, an increase in non-
LCMV–specific antibodies is associated with persistent viral 
infections (Hunziker et al., 2003). This non–virus-specific JEM VOL. 208, May 9, 2011 
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isotype controls (BD); CD4-Pacific blue, ICOS-FITC, OX40-PE, SLAM-
Alexa Fluor 488, B220-Pacific blue (BioLegend); Ly5.1-PerCP-Cy5.5, 
Fas-PE (eBioscience); and Bcl6-PE (Santa Cruz Biotechnology, Inc.). LCMV 
GP66-77 tetramers were provided by the National Institutes of Health Tetra-
mer Core Facility. Flow cytometric analysis was performed using the Digital 
LSR II (BD) at the UCLA Jonsson Comprehensive Cancer Center and Cen-
ter for AIDS Research Flow Cytometry Core Facility.
Immunofluorescence microscopy. Fresh spleen sections were embedded 
and frozen on dry ice in optimal cutting temperature (OCT; TissueTek). 6-µm 
frozen cryostat sections were cut, fixed in 4% paraformaldehyde for 10 min, 
blocked with an avidin/biotin blocking kit (Vector Laboratories), and stained 
with CD45.1-biotin (BioLegend), CD4-FITC (BD), or B220-APC (Bio-
Legend). After the primary antibody incubation, sections were washed in 
PBS and stained with anti-APC (BioLegend) conjugated to Alexa Fluor 647 
(Invitrogen) and SA-Rhodamine Red-X (Jackson ImmunoResearch Labo-
ratories). After the second stain, the sections were washed in PBS, incubated 
with biotinylated anti-SA (Vector Laboratories), washed again in PBS, and 
then stained with SA-Rhodamine Red-X. Sections were visualized using an 
immunofluorescence microscope (Zeiss Axio Observe Z1; Carl Zeiss, Inc.), 
and images were captured with AxioCam MRm camera (Carl Zeiss, Inc.) 
using a 20× objective. Reconstructions were performed using the MosaiX 
function in AxioVision software (Carl Zeiss, Inc.). The images were prepared 
using AxioVision software and Photoshop (Adobe).
Quantitative RT-PCR. Splenocytes were harvested on day 9 or 30 after 
infection. Virus-specific CD4 T cells were FACS isolated based on CD4+, 
Ly5.1+ staining (after sort purity was >97%). RNA from purified virus-specific 
CD4 T cells was isolated with the RNEasy extraction kit (QIAGEN) and 
analyzed using the RT2 Profiler PCR array mouse Th1-Th2-Th3 kit   
(SABiosciences). mRNA was detected using the iCycler (Bio-Rad Labora-
tories) and normalized to five housekeeping genes.
To specifically assess mRNA expression in naive, virus-specific Tfh and 
non-Tfh cells. Naive virus-specific CD4+ T cells were purified from spleens 
of naive Ly5.1+ SMARTA mice by negative selection (StemCell Technolo-
gies). Virus-specific Tfh and non-Tfh cells were FACS isolated from spleno-
cytes harvested on day 32 after LCMV-Cl 13 infection. Virus-specific CD4   
T cells were sorted based on CD4+, Ly5.1+, CXCR5+ (Tfh) or CD4+, Ly5.1+ 
CXCR5 (non-Tfh) expression. RNA from purified virus-specific CD4   
T cells was isolated with the RNEasy extraction kit. Individual RNA was 
amplified using Applied Biosystems TaqMan expression assays and normal-
ized to HPRT. mRNA was detected using the iCycler.
ELISA. To quantify LCMV-specific antibodies, LCMV-Cl 13 was used to 
coat 96-well Maxisorp ELISA plates (Nunc) overnight. Plates were blocked 
with 3% BSA/PBS/0.05% Tween 20. Subsequently, serum isolated from the 
indicated mice was incubated on the LCMV-coated plates. Plates were 
washed and incubated with an HRP-labeled goat anti–mouse IgG antibody 
(Invitrogen), followed by the addition of o-phenylenediamine substrate in 
0.05 M phosphate citrate buffer. The reaction was stopped with 2N H2SO4, 
and the optical density values were read using an ELISA plate reader (Syn-
ergy 2; BioTek) at 490 nm. The concentration of antibody was interpolated 
from a standard curve. The standard curve was generated from a serial dilu-
tion of purified mouse IgG (Invitrogen; 500–0.49 ng/ml) incubated on plates 
coated with goat anti–mouse IgG (Invitrogen). To assess specific antibody 
isotypes, LCMV-coated plates were incubated with serum from LCMV-Arm 
or Cl 13–infected mice, and then incubated with biotinylated goat anti–
mouse IgG1, IgG2a, IgG2b, or IgG3 (BioLegend). The plates were subse-
quently incubated with a SA-HRP (BioLegend), and specific levels of each 
antibody isotype was measured as stated above.
In vitro B cell help assay.  Virus-specific Tfh and non-Tfh cells were FACS 
purified from splenocytes harvested on day 28 after LCMV-Cl 13 infection. 
Virus-specific CD4 T cells were sorted based on CD4+, Ly5.1+, CXCR5+ 
(Tfh) or CD4+, Ly5.1+ CXCR5 (non-Tfh) expression. Naive B cells were 
In all experiments the mice were infected i.v via the retroorbital sinus with 
2 × 106 PFU of LCMV-Arm or LCMV-Cl 13. Virus stocks were prepared 
and viral titers were quantified as described previously (Brooks et al., 2005).
Isolation and adoptive transfer of virus-specific CD4 T cells. To spe-
cifically identify and isolate virus-specific CD4 T cells, CD4+ T cells were 
purified from the spleens of naive Ly5.1+ SMARTA mice by negative selec-
tion (StemCell Technologies). After purification, 500–1000 cells were trans-
ferred  i.v.  into  6–8-wk-old  Ly5.2+  C57BL6  mice. The  transfers  enabled 
identification and isolation of LCMV-specific CD4 T cells separately from 
endogenous responses. We avoided the problems associated with using large, 
nonphysiological numbers of transferred transgenic T cells (Marzo et al., 
2005) by only transferring low numbers of transgenic T cells. Mice were then 
infected with LCMV-Arm or LCMV-Cl 13 1 d after cell transfer. For experi-
ments in which intrahepatic lymphocytes were analyzed, mice were per-
fused with 25 ml of sterile PBS by cardiac injection to remove blood from 
all tissues. Intrahepatic lymphocytes were isolated by centrifugation in 
35% Percoll (GE Healthcare). The absolute number of Tfh and non-Tfh 
SMARTA  cells was determined by multiplying the frequency of CD4+, 
Ly5.1+, CXCR5+ cells or CD4+, Ly5.1+, CXCR5 cells, respectively, by the 
total number of cells in the organ.
To determine whether non-Tfh cells progressively differentiate into Tfh 
cells during persistent infection, SMARTA cells were adoptively transferred 
into  C57BL6  mice  that  were  subsequently  infected  with  LCMV-Cl  13. 
Spleens from these mice were isolated on day 9 after infection, depleted of   
B cells (>98% removed) using anti-CD19 MACs beads (Miltenyi Biotec), 
FACS sorted based on CD4+, CXCR5, and adoptively transferred into day 12 
LCMV-Cl 13–infected C57BL6 mice that had not originally received 
SMARTA cells. We transferred into day 12 infected mice (after the start of 
CD4 T cell contraction) to avoid introducing large numbers CD4 T cells 
during the peak of the immune response, which may increase immuno-
pathology and mortality. Spleens from recipient mice were analyzed 14 d   
after transfer (23 d after infection for the SMARTA cells).
To assess the contribution of immune activation and TCR stimulation 
toward virus-specific CD4 T cell differentiation, SMARTA cells were adoptively 
transferred into C57BL6 mice and subsequently infected with LCMV-Cl 13. 
Spleens from these mice were isolated on day 35 after infection, depleted of 
B cells (>98% removed) using anti-CD19 MACs beads, and then adoptively 
transferred into C57BL6 LCMV-Arm–immune, LCMV-Cl 13–infected mice 
or into LCMV-Cl 13–infected MHC class II–deficient mice that had been 
infected in parallel but had not originally received SMARTA cells. Spleens 
from recipient mice were analyzed 14 d after cell transfer.
In vivo CD4 depletion. To deplete CD4 T cells before LCMV infection, 
mice were injected i.p. with 500 g anti-CD4 antibody (clone GK1.5) and 
infected 1 d later. To deplete CD4 T cells during infection, C57BL6 mice 
were injected i.v. once daily for 3 consecutive days with either 1 mg of the 
isotype control antibody (LTF-2) or of anti-CD4 antibody (YTS 191; Bio-
XCell). In all cases, CD4 T cell depletion was confirmed via flow cytometry.
Bone marrow chimera experiments. To perform mixed bone marrow 
chimera experiments WT C57BL6 recipient mice were lethally irradiated 
with 950 rads. On the same day, the irradiated mice were injected with a 
mixture of bone marrow cells from CD4 KO (85%) and WT (15%) mice or 
CD4 KO (85%) and CXCR5 KO (15%) mice. Bone marrow cells were iso-
lated from femurs and tibia of donor mice. 20 million total cells were trans-
ferred (i.v.) into the recipient mice. The recipient mice were treated with 
antibiotics (Sulfamethoxazole and Trimethoprim in the drinking water) for   
3 wk to prevent infection and allow for immune reconstitution. Reconstitu-
tion was confirmed 8 wk after bone marrow transfer, and the mice were sub-
sequently infected with LCMV-Cl 13.
Flow cytometry. Splenocytes were stained ex vivo with LCMV-GP66-77 
tetramers,  LCMV-GP33-41  tetramers,  and/or  for  the  expression  of  CD4-
APC-Cy7, CD8-FITC, CXCR5-biotin/streptavidin (SA)-APC, GL7-FITC, 998 Viral persistence drives T follicular helper cell differentiation | Fahey et al.
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